Shijiazhuang Yiling Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the sixteenth meeting of the seventh board of directors on September 15, 2021, and resolved to convene the company's 2021 third extraordinary general meeting of shareholders